SCHEMBL24140944

SCHEMBL24140944

CCNc1ccc(-c2nncnn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ TP53 P04637 3/20 0.48
▸ ADRA2A P08913 7/20 0.38
▸ ADRA2B P18089 3/20 0.38
▸ ADRA2C P18825 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RAD51 Q06609 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CYP1A2 P05177 3/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ KMT2A Q03164 2/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ EGLN2 Q96KS0 1/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22154712 0.78 MAPT (0.53) MAPTKDM4ETP53ALDH1A1NPC1
SCHEMBL7012895 0.76 LMNA (0.56) MAPTTP53ADRA2AADRA2BADRA2C
SCHEMBL11544937 0.76 LMNA (0.56) MAPTTP53ADRA2AADRA2BADRA2C
SCHEMBL21372065 0.76 MAPT (0.65) MAPTKDM4ETP53LMNAALDH1A1
SCHEMBL14516252 0.74 ADRB2 (0.47) MAPTKDM4EADRA2AADRA2BADRA2C
SCHEMBL19543315 0.74 MAPT (0.50) MAPTKDM4ETP53ALDH1A1NPC1
SCHEMBL15383744 0.74 TP53 (0.53) MAPTKDM4ETP53LMNAALDH1A1
SCHEMBL20783238 0.74 TP53 (0.48) MAPTKDM4ETP53NPC1RAB9A
SCHEMBL526383 0.73 MAPT (0.58) MAPTKDM4ETP53ADRA2AADRA2B
SCHEMBL24303801 0.73 LMNA (0.50) MAPTKDM4ELMNARAD51ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021262910-A2 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES REGENERON PHARMACEUTICALS, INC. (US) 2021-12-30 — — WO disclosed
Send feedback